Advances in the Molecular Pathogenesis of Acute Myeloid Leukemia

Read full text Summarise with VIRAT
Authors: Rusul Ahmed Mohammed, Nada Khazal K. Hindi, Mustafa Hussein Mohammed, Zahraa I. J. Shubber, Abdolmajid Ghasemian
Cited by: 0
References: 58

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Acute Myeloid Leukemia comprises a heterogeneous group of clonal disorders that result from the abnormal accumulation of immature myeloid cells within the bone marrow and peripheral blood. This study aims to detect Advances in the Molecular Pathogenesis of Acute Myeloid Leukemia. This has been elucidated by recent molecular studies that identified crucial mutations in FLT3, NPM1, and DNMT3A genes and epigenetic changes that contribute to leukemogenesis. Deregulated pathways besides PI3K/AKT and MAPK have also asserted themselves in disease progression and resistance to therapy. Hence, the review presents an extensive discussion of contemporary molecular perspectives of AML pathogenesis and their relevance to diagnosis and treatment. The rise in targeted therapies and precision medicine thus paints a promising clinical picture for a better prognosis. Knowledge of the biological compromise unleashed by mutations in genes and their interplay with the bone marrow microenvironment is key to forging newer therapies.

Fields of Study & Subjects

Acute Myeloid Leukemia Research Retinoids in leukemia and cellular processes Chronic Myeloid Leukemia Treatments

Publication details

Journal / source
Journal of Biomedicine and Biochemistry
Volume
5
Issue
1
Pages
56–70
Publication date
30 March 2026
Language
EN